1 study found for:    ((BAY86-9766 AND GIST) OR NCT01392521)
Show Display Options
RSS Create an RSS feed from your search for:
((BAY86-9766 AND GIST) OR NCT01392521)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced Cancer
Condition: Neoplasms
Intervention: Drug: Copanlisib + Refametinib (BAY86-9766)

Indicates status has not been verified in more than two years